logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
R

Rheumatology and Therapy

IF2.9
论文数153
被引数2022
期刊论文 153
发表时间
delete
Interleukin-6 Blockade in Refractory Neuro-Behçet’s Disease: A Systematic Literature Review白介素-6阻断治疗难治性神经白塞病的系统文献综述
deleteRheumatology and Therapy
IF2.9
delete2026-10-26
delete0
deleteOAAI
deleteAyaka Maeda; Yuki Iizuka; Kaoru Takase-Minegishi; Yuji Yoshioka; Yutaro Soejima; Miki Hoshi; Eijin Hashimoto; Chiharu Hidekawa; Takaaki Komiya; Daiga Kishimoto; Ryusuke Yoshimi; Yohei Kirino; Hideaki Nakajima
delete分享
delete收藏
Patient-Reported Disease Activity, Health-Related Quality of Life, and Coping in Systemic Lupus Erythematosus: A Cross-Sectional Online Survey in Switzerland (Lupus-IMPACT)系统性红斑狼疮患者报告的疾病活动度、健康相关生活质量及应对方式：瑞士一项横断面在线调查（Lupus-IMPACT）
deleteRheumatology and Therapy
IF2.9
delete2026-10-25
delete0
deleteOAAI
deleteMarten Trendelenburg; Jasmin Annabelle Schulz; Kristin Schmiedeberg; Johannes von Kempis; Alessandra Girardi; Marie-Louise Hagen-Perrenoud; Chiara Balbo Pogliano; Philipp M. Wörner; Peter Langer; Shekoofeh Yaghmaei; Carlo Chizzolini
delete分享
delete收藏
Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study贝美克单抗在中国活动性非放射影像性轴向脊柱关节炎患者中的疗效：3期BE MOBILE 1研究52周结果
deleteRheumatology and Therapy
IF2.9
delete2026-10-23
delete0
deleteOAAI
deleteJieruo Gu; Liangjing Lu; Qiang Wang; Xiaobing Wang; Yongjing Cheng; Shengqian Xu; Yi Zhao; Qi Zhu; Xenofon Baraliakos; Matthew A. Brown; Atul Deodhar; James Cheng-Chung Wei; Alexander Marten; Marga Oortgiesen; Tom Vaux; Huji Xu
delete分享
delete收藏
Impact of the Sociodemographic Index on Efficacy/Safety of Tofacitinib in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Phase 2/3/3b/4 Studies社会人口指数对类风湿关节炎患者托法替布疗效/安全性的影响：对II/III/IIIb/IV期研究的回顾性分析
deleteRheumatology and Therapy
IF2.9
delete2026-10-16
delete0
deleteOAAI
deleteGrace Wright; Eduardo Mysler; Kevin D. Roberts; Ahmed Shelbaya; Lindsay Sweet; Karim R. Masri
delete分享
delete收藏
Effectiveness of Newly Initiated Tofacitinib and Biologic DMARDs in Patients with Rheumatoid Arthritis新启动托法替布和生物制剂改善病情抗风湿药在类风湿关节炎患者中的疗效
deleteRheumatology and Therapy
IF2.9
delete2026-10-15
delete0
deleteOAAI
deleteKatherine P. Liao; Chandrasekar Gopalakrishnan; Jinoos Yazdany; Suraj Sarvode Mothi; Genevieve Gauthier; Griffith Bell; Arne Yndestad; Milena A. Gianfrancesco
delete分享
delete收藏
Long-Term Safety and Efficacy of Upadacitinib in Patients with Psoriatic Arthritis: 5-Year Results from the Phase 3 SELECT-PsA 1 Study乌帕替尼在银屑病关节炎患者中的长期安全性和有效性：3期SELECT-PsA 1研究5年结果
deleteRheumatology and Therapy
IF2.9
delete2026-10-07
delete0
deleteOAAI
deleteIain B. McInnes; Koji Kato; Marina Magrey; Joseph F. Merola; Mitsumasa Kishimoto; Derek Haaland; Laura C. Coates; Ivan Lagunes; Yanxi Liu; Erin Mancl; Bhumik Parikh; Charles Philips
delete分享
delete收藏
Sociodemographic and Clinical Determinants of Colchicine Adherence in Adults with Familial Mediterranean Fever: A Cross-Sectional Study地中海热成人患者秋水仙碱依从性的社会人口统计学和临床决定因素：一项横断面研究
deleteRheumatology and Therapy
IF2.9
delete2026-09-25
delete0
deleteOAAI
deleteErtugrul Cagri Bolek; Emre Bilgin; Riza Can Kardas; Levent Kilic; Sedat Kiraz; Ali Ihsan Ertenli; Alper Sari; Ali Akdogan
delete分享
delete收藏
Updates on the Evaluation of Lupus Arthritis系统性红斑狼疮关节炎评估的进展
deleteRheumatology and Therapy
IF2.9
delete2026-09-04
delete0
deleteOAAI
deleteWei Tang; Alberto Nordmann-Gomes; Leila Khalili; Giovanna Rosas; Ellen Montgomery; Laurel Zhang; Stephen Suh; Robert Clancy; Anca D. Askanase
delete分享
delete收藏
Real-World Steroid Burden, Treatment Patterns, and Rheumatologists’ Perceptions on Advanced Therapy in Giant Cell Arteritis真实世界糖皮质激素负担、治疗模式及风湿病学家对巨细胞动脉炎先进疗法的看法
deleteRheumatology and Therapy
IF2.9
delete2026-08-28
delete0
deleteOAAI
deleteAnisha B. Dua; Aditi Kadakia; Patrick Zueger; Simran Marwaha; Nathaniel Zerad; Arathi Setty; William Jones; Valerie Devauchelle-Pensec
delete分享
delete收藏
Fertility and Birth Outcomes in Rheumatoid Arthritis: A Narrative Review类风湿关节炎的生育能力和出生结局：一项叙事综述
deleteRheumatology and Therapy
IF2.9
delete2026-08-20
delete0
deleteOAAI
deleteNoel L. Ermer; Lisa R. Sammaritano; Caroline H. Siegel
delete分享
delete收藏
Correction: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study修正：静脉注射免疫球蛋白对皮肌炎系统性表现的疗效：超越肌肉和皮肤——ProDERM研究的亚组分析
deleteRheumatology and Therapy
IF2.9
delete2026-08-13
delete0
deleteOAAI
deleteRohit Aggarwal; Joachim Schessl; Zsuzsanna Bata-Csörgő; Mazen M. Dimachkie; Zoltan Griger; Sergey Moiseev; Chester V. Oddis; Elena Schiopu; Jiri Vencovský; Elisabeth Clodi; Todd Levine; Christina Charles-Schoeman
delete分享
delete收藏
Subcutaneous Belimumab Demonstrates Consistent Steady-State Pharmacokinetics and is Well Tolerated in Paediatric Patients with SLE in China: An Open-Label Study中国儿童SLE患者中皮下注射贝利木单抗显示出一致的稳态药代动力学特征且耐受性良好：一项开放标签研究
deleteRheumatology and Therapy
IF2.9
delete2026-08-08
delete0
deleteOAAI
deleteCaifeng Li; Junmei Zhang; Meiping Lu; Haiguo Yu; Li Sun; Qihua Feng; Zhihui Li; Jane Chen; Tiantian Liu; Junyi Wu; Xuan Zhou; Haomin Qiu
delete分享
delete收藏
Longitudinal Instability of Minimal Disease Activity Domains in Psoriatic Arthritis with Fluctuating Response: A Trajectory Analysis of a Real-World Cohort银屑病关节炎中波动应答下最小疾病活动度领域的纵向不稳定性：一项真实世界队列的轨迹分析
deleteRheumatology and Therapy
IF2.9
delete2026-07-31
delete0
deleteOAAI
deleteMauro Fatica; Fabio Massimo Perrotta; Noemi Italiano; Eneida Çela; Maria Sole Chimenti; Ennio Lubrano
delete分享
delete收藏
Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies菲戈替尼在真实世界中度至重度类风湿关节炎中的疗效：基于FILOSOPHY和PARROTFISH研究（超过1400例患者）的6个月疗效、患者报告结局和持续用药情况以及24个月安全性
deleteRheumatology and Therapy
IF2.9
delete2026-07-31
delete0
deleteOAAI
deleteGerd R. Burmester; James Galloway; Karen Bevers; Jérôme Avouac; Susana Romero-Yuste; Roberto F. Caporali; Neil Betteridge; Carole Van der Donckt; Thomas P. A. Debray; Ouafia Tandjaoui Bouzid; Patrick Verschueren
delete分享
delete收藏
Persistence Among Biologic/JAKi-Naive Medicare Beneficiaries with RA Initiating Synthetic DMARDs生物制剂/Janus激酶抑制剂初治的RA患者中启动合成DMARDs的持续性
deleteRheumatology and Therapy
IF2.9
delete2026-07-24
delete0
deleteOAAI
deleteTaylor T. Schwartz; Hanke Zheng; Laetitia N’Dri; Sang Hee Park; Kristofer Norris; Vardhaman A. Patel; Scott B. Robinson; Keith Wittstock; Vadim Khaychuk; Alison R. Silverstein; Jeffrey A. Sparks
delete分享
delete收藏
Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF Inhibitor在初次使用一种TNF抑制剂后，接受类风湿关节炎先进治疗患者的长期依从性和转换率比较
deleteRheumatology and Therapy
IF2.9
delete2026-07-14
delete0
deleteOAAI
deleteChristina Charles-Schoeman; Kurt Oelke; Patrick M. Zueger; Yi Peng; Gregory Markley; Richard Thielen; Siran Fang; Martin Bergman
delete分享
delete收藏
Duration of Belimumab Therapy and Timing of Initiation as Predictors of Clinical Outcomes in Childhood-Onset Systemic Lupus Erythematosus: A Real-World Retrospective Study贝利木单抗治疗持续时间及起始时间作为儿童系统性红斑狼疮临床结局预测因子的真实世界回顾性研究
deleteRheumatology and Therapy
IF2.9
delete2026-07-11
delete0
deleteOAAI
deleteBaixu Sun; Shipeng Li; Fengqiao Gao; Shuo Liu; Wei Zhao; Junmei Zhang; Xiaohua Tan; Chao Li; Caifeng Li
delete分享
delete收藏
Comparison of Systemic Corticosteroid Therapy Practices Between Pediatric and Adult Rheumatologists: A Multicenter Survey Study比较儿科与成人风湿病医师系统性皮质类固醇治疗实践：一项多中心调查研究
deleteRheumatology and Therapy
IF2.9
delete2026-06-25
delete0
deleteOAAI
deleteÖvgü Özenli Yağcı; Çisem Yıldız; Deniz Gezgin Yıldırım; Emre Bilgin; Sevcan A. Bakkaloğlu
delete分享
delete收藏
Psychological Aspects of Rheumatic Diseases: Psychorheumatology in Clinical Practice风湿病的心理方面：临床实践中的心理风湿病学
deleteRheumatology and Therapy
IF2.9
delete2026-06-23
delete0
deleteOAAI
deleteDomniki M. Karagianni; Christina G. Katsiari; Konstantinos Bonotis; Lazaros I. Sakkas
delete分享
delete收藏
Effectiveness and Safety of Inebilizumab for IgG4-Related Disease in a Real-World Clinical Setting in Japan: Protocol for a Long-Term Prospective Observational Study (4SigHT Study)日本真实世界临床环境中伊尼珠单抗治疗IgG4相关疾病的疗效与安全性：一项长期前瞻性观察研究的方案（4SigHT研究）
deleteRheumatology and Therapy
IF2.9
delete2026-06-22
delete0
deleteOAAI
deleteYoshiya Tanaka; Yuzo Kodama; Shingo Nakayamada; Atsushi Masamune; Hirokazu Sato; Akiko Takahashi; Junichiro Shibata; Yusuke Takeshima; Mitsuhiro Kawano
delete分享
delete收藏